4890 — Tsubota Laboratory Balance Sheet
0.000.00%
- ¥9bn
- ¥7bn
- ¥1bn
- 64
- 11
- 10
- 14
Annual balance sheet for Tsubota Laboratory, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 611 | 1,175 | 2,161 | 1,883 | 1,539 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 148 | 4.09 | 26.9 | 46.9 | 608 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,004 | 1,515 | 2,569 | 2,224 | 2,445 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 46.1 | 70.7 | 77.9 | 52.7 | 44 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,079 | 1,618 | 2,673 | 2,295 | 2,503 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 264 | 674 | 608 | 838 | 847 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 488 | 873 | 723 | 928 | 916 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 591 | 744 | 1,950 | 1,367 | 1,587 |
| Total Liabilities & Shareholders' Equity | 1,079 | 1,618 | 2,673 | 2,295 | 2,503 |
| Total Common Shares Outstanding |